A discrete choice experiment to assess patients’ preferences for HIV treatment in the rural population in Colombia

References

• World Health Organisation. Number of people (all ages) living with HIV Estimates by WHO region 2017 [cited 2020 Feb 27]. Available from: http://apps.who.int/gho/data/view.main.22100WHO?lang=en.
   Google Scholar
• UNAIDS. UNAIDS data 2017. Geneva: UNAIDS; 2017.
   Google Scholar
• Weiss RA. How does HIV cause AIDS? Science-New York Then Washington. 1993;260(5112):1273–1273.
   PubMed Web of Science ®Google Scholar
• Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50(s3):S85–S95.
   PubMed Web of Science ®Google Scholar
• Organization WH. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016.
   Google Scholar
• Organisation WH. Treatment and care 2018 [cited 2020 Feb 27]. Available from: http://www.who.int/hiv/topics/treatment/en/.
   Google Scholar
• Guía de práctica clínica. Basada en la evidencia científica para la atención de la infección por VIH/Sida en adolescentes (con 13 años de edad o más) y adultos. GPC-2014-39. [cited 2019 Nov 13]. http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_VIH_adolescentes/GPC_Comple_VIHADULTOS_web.pdf.
   Google Scholar
• Keaei M, Kuhlmann J, Conde R, et al. Health-related quality of life of patients with HIV/AIDS in Bogota, Colombia. Value Health Reg Issues. 2016;11:68–72.
   PubMedGoogle Scholar
• Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376(9734):49–62.
   PubMed Web of Science ®Google Scholar
• Mannheimer SB, Matts J, Telzak E, et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care. 2005;17(1):10–22.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Gerver SM, Fidler S, et al. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS (London, England). 2014;28(13):1945–1956.
   PubMed Web of Science ®Google Scholar
• Eldredge LKB, Markham CM, Ruiter RA, et al. Planning health promotion programs: an intervention mapping approach. New York (NY): John Wiley & Sons; 2016.
   Google Scholar
• Clark MD, Determann D, Petrou S, et al. Discrete choice experiments in health economics: a review of the literature. Pharmacoeconomics. 2014;32(9):883–902.
   PubMed Web of Science ®Google Scholar
• Lancsar E, Louviere J. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics. 2008;26(8):661–677.
   PubMed Web of Science ®Google Scholar
• Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ: Br Med J. 2000;320(7248):1530–1533.
   PubMed Web of Science ®Google Scholar
• Gazzard B, Ali S, Muhlbacher A, et al. Patient preferences for characteristics of antiretroviral therapies: results from 5 European countries. J Int AIDS Soc. 2014;17(4):19540.
   PubMed Web of Science ®Google Scholar
• Muhlbacher AC, Stoll M, Mahlich J, et al. Patient preferences for HIV/AIDS therapy – a discrete choice experiment. Health Econ Rev. 2013;3(1):14. PubMed PMID: 23663390; PubMed Central PMCID: PMCPMC3662594.
   PubMedGoogle Scholar
• Brégigeon-Ronot S, Cheret A, Cabié A, et al. Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France. Patient Prefer Adher. 2017;11:1159–1169.
   PubMed Web of Science ®Google Scholar
• Ostermann J, Njau B, Brown DS, et al. Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One. 2014;9(3):e92100.
   PubMed Web of Science ®Google Scholar
• Youngkong S, Baltussen R, Tantivess S, et al. Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment. BMC Health Serv Res. 2010;10(1):197.
   PubMed Web of Science ®Google Scholar
• Quaife M, Eakle R, Cabrera M, et al. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment. BMJ Open. 2016;6(6):e010682.
   PubMed Web of Science ®Google Scholar
• Hendriks A, Wijnen B, van Engelen R, et al. A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment. J Med Econ. 2018;21(5):468–473.
   PubMed Web of Science ®Google Scholar
• Ryan M, Gerard K, Amaya-Amaya M. Discrete choice experiments in a nutshell. Using discrete choice experiments to value health and health care. Dordrecht: Springer; 2008. p. 13–46.
   Google Scholar
• Nieto S, Ramos R, Duque JC, editors. Rural-urban differences in educational outcomes: evidence for Colombia using PISA microdata. ERSA conference papers; 2012. European Regional Science Association.
   Google Scholar
• Schultz TP. Rural-urban migration in Colombia. Rev Econ Stat. 1971;53(2):157–163.
   Web of Science ®Google Scholar
• Goeree R, He J, O’Reilly D, et al. Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clin Econ Outcomes Res. 2011;3:89.
   PubMedGoogle Scholar
• Bridges JF, Hauber AB, Marshall D, et al. Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–413.
   PubMed Web of Science ®Google Scholar
• Coast J, Al‐Janabi H, Sutton EJ, et al. Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations. Health Econ. 2012;21(6):730–741.
   PubMed Web of Science ®Google Scholar
• Helter TM, Boehler C. Developing attributes for discrete choice experiments in health: a systematic literature review and case study of alcohol misuse interventions. J Subst Use. 2016;21(6):662–668.
   PubMed Web of Science ®Google Scholar
• Michaels-Igbokwe C, Lagarde M, Cairns J, et al. Using decision mapping to inform the development of a stated choice survey to elicit youth preferences for sexual and reproductive health and HIV services in rural Malawi. Soc Sci Med. 2014;105:93–102.
   PubMed Web of Science ®Google Scholar
• Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16(1):3–13.
   PubMed Web of Science ®Google Scholar
• Hauber AB, Mohamed AF, Watson ME, et al. Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments. AIDS Patient Care STDs. 2009;23(1):29–34.
   PubMed Web of Science ®Google Scholar
• Sijstermans E, Cheung KL, Goossens AJM, et al. A discrete choice experiment to assess patients’ preferences for HIV treatment in the urban population in Colombia. doi:10.1080/13696998.2020.1735399.
   Google Scholar
• Cohen MS, Gay C, Kashuba AD, et al. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1antiretroviral therapy for preventing the sexual transmission of HIV-1. Ann Intern Med. 2007;146(8):591–601.
   PubMed Web of Science ®Google Scholar
• Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49(9):796–804.
   PubMed Web of Science ®Google Scholar
• de Bekker-Grob EW, Donkers B, Jonker MF, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient. 2015;8(5):373–384.
   PubMedGoogle Scholar